291 related articles for article (PubMed ID: 15998443)
41. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice.
Yamashiki M; Mase A; Arai I; Huang XX; Nobori T; Nishimura A; Sakaguchi S; Inoue K
Clin Sci (Lond); 2000 Nov; 99(5):421-31. PubMed ID: 11052923
[TBL] [Abstract][Full Text] [Related]
42. [Protective effects of artesunate against Con A-induced autoimmune liver injury in mice].
Cao J; Zhao X; Liu MJ; Zheng H; Li JG
Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):2123-2128. PubMed ID: 29933681
[TBL] [Abstract][Full Text] [Related]
43. Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis.
Sharma M; Mohapatra J; Malik U; Wagh A; Singh A; Patel HM; Pandey D; Kadam S; Shah GB; Chatterjee A; Jain MR
Int Immunopharmacol; 2013 Oct; 17(2):229-36. PubMed ID: 23816535
[TBL] [Abstract][Full Text] [Related]
44. Diallyl trisulfide protects against concanavalin A-induced acute liver injury in mice by inhibiting inflammation, oxidative stress and apoptosis.
Ding Y; Yu Z; Zhang C
Life Sci; 2021 Aug; 278():119631. PubMed ID: 34022202
[TBL] [Abstract][Full Text] [Related]
45. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
46. Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent.
Ding JW; Wang K; Brems JJ; Gamelli RL
J Am Coll Surg; 2004 Jan; 198(1):67-77. PubMed ID: 14698313
[TBL] [Abstract][Full Text] [Related]
47. The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury.
Xu X; Wei H; Dong Z; Chen Y; Tian Z
Inflamm Res; 2006 Apr; 55(4):144-52. PubMed ID: 16807695
[TBL] [Abstract][Full Text] [Related]
48. CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice.
Zhang H; Gong Q; Li JH; Kong XL; Tian L; Duan LH; Tong J; Song FF; Fang M; Zheng F; Xiong P; Tan Z; Gong FL
Int Immunopharmacol; 2010 Jan; 10(1):79-85. PubMed ID: 19818415
[TBL] [Abstract][Full Text] [Related]
49. Development of anorexia in concanavalin A-induced hepatitis in mice.
Okamoto T; Okabe S
Int J Mol Med; 2001 Feb; 7(2):169-72. PubMed ID: 11172620
[TBL] [Abstract][Full Text] [Related]
50. [Sodium butyrate inhibits HMGB1 expression and release and attenuates concanavalin A-induced acute liver injury in mice].
Gong Q; Chen MJ; Wang C; Nie H; Zhang YX; Shu KG; Li G
Sheng Li Xue Bao; 2014 Oct; 66(5):619-24. PubMed ID: 25332009
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide.
Liu DF; Wei W; Song LH
Acta Pharmacol Sin; 2006 Apr; 27(4):460-8. PubMed ID: 16539847
[TBL] [Abstract][Full Text] [Related]
52. Protective effects of hesperidin on concanavalin A-induced hepatic injury in mice.
Li G; Chen MJ; Wang C; Nie H; Huang WJ; Yuan TD; Sun T; Shu KG; Wang CF; Gong Q; Tang SQ
Int Immunopharmacol; 2014 Aug; 21(2):406-11. PubMed ID: 24867793
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.
Bozza M; Bliss JL; Maylor R; Erickson J; Donnelly L; Bouchard P; Dorner AJ; Trepicchio WL
Hepatology; 1999 Dec; 30(6):1441-7. PubMed ID: 10573523
[TBL] [Abstract][Full Text] [Related]
54. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice.
Nakamura K; Okada M; Yoneda M; Takamoto S; Nakade Y; Tamori K; Aso K; Makino I
J Hepatol; 2001 Aug; 35(2):217-24. PubMed ID: 11580144
[TBL] [Abstract][Full Text] [Related]
55. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
56. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.
Luo Q; Wang Y; Feng D; Xu Y; Xu L
Eur J Pharmacol; 2009 Apr; 607(1-3):226-33. PubMed ID: 19222997
[TBL] [Abstract][Full Text] [Related]
58. Hepatoprotective effects of reynosin against thioacetamide-induced apoptosis in primary hepatocytes and mouse liver.
Lim S; Lee SJ; Nam KW; Kim KH; Mar W
Arch Pharm Res; 2013 Apr; 36(4):485-94. PubMed ID: 23435943
[TBL] [Abstract][Full Text] [Related]
59. Protective effect of JBP485 on concanavalin A-induced hepatocyte toxicity in primary cultured rat hepatocytes.
Wu J; Wang C; Liu Q; Yang T; Zhang Q; Peng J; Gao Y; Sun H; Kaku T; Liu K
Eur J Pharmacol; 2008 Jul; 589(1-3):299-305. PubMed ID: 18571156
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of specific cannabinoid receptor 2 agonist GW405833 on concanavalin A-induced acute liver injury in mice.
Huang ZB; Zheng YX; Li N; Cai SL; Huang Y; Wang J; Hu XW; Wang Y; Wu J; Fan XG
Acta Pharmacol Sin; 2019 Nov; 40(11):1404-1411. PubMed ID: 30918343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
